Next, experiments using in vivo orthotopic lung cancer model showed that the nude mice implanted with SK-MES-1 LV-FGF19 cells presented increased bioluminescent imaging (BLI) signals, augmented tumor volume in the lung, and significantly increased PCNA expression, resulting in a shorter overall survival time. This evidence concerns the gene FGF19 and lung carcinoma.